Obesity trials in South Korea
36 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseRecruitingTrial-stage medicine
Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
- Where
- Seoul
- Age
- 19 years to 50 years
- People
- 30
- Run by
- Seoul National University Hospital
See details and how to joinNCT07732426Registry updated 2026-07-28
No phaseNot yet recruitingTrial-stage medicine
Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
- Where
- Hwaseong-si, Seongnam-si
- Age
- 20 years to 70 years
- People
- 80
- Run by
- Hallym University
See details and how to joinNCT07621640Registry updated 2026-07-22
No phaseEnrolling by invitationResearch participation
The Efficacy and Safety of Herbal Medicine Treatment for Obese Patients With Spinal and Joint Pain
- Where
- Seoul
- Age
- 19 years to 69 years
- People
- 40
- Run by
- Jaseng Medical Foundation
See details and how to joinNCT06859697Registry updated 2026-07-02
No phaseEnrolling by invitationResearch participation
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
- Where
- Seoul
- Age
- 19 years and over
- People
- 800,000
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07673822Registry updated 2026-06-29
Phase 2RecruitingTrial-stage medicine
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
- Where
- Seoul, Suwon
- Age
- 18 years and over
- People
- 75
- Run by
- NeuroBiogen Co., Ltd
See details and how to joinNCT07009171Registry updated 2026-06-24
Phase 2RecruitingTrial-stage medicine
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Busan, Goyang-si, Gyeonggi-do, Seoul
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698EU 2024-510846-15-00Registry updated 2026-03-11
Phase 4RecruitingTrial-stage medicine
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
- Where
- Seoul
- Age
- 20 years to 79 years
- People
- 30
- Run by
- Korea University Anam Hospital
See details and how to joinNCT06782139Registry updated 2025-09-02
No phaseRecruitingResearch participation
Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
- Where
- Seongnam-si
- Age
- 19 years to 65 years
- People
- 92
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT07051109Registry updated 2025-07-03
No phaseEnrolling by invitationResearch participation
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea
- Where
- Busan, Chungcheongnam-do, Daejeon, Goyang-si, Gyeonggi-do, Seoul, Yangsan
- Age
- 19 years and over
- People
- 840
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07018544Registry updated 2025-06-12
No phaseRecruitingResearch participation
Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx
- Where
- Seoul
- Age
- 20 years to 80 years
- People
- 40
- Run by
- SMG-SNU Boramae Medical Center
See details and how to joinNCT06426810Registry updated 2024-05-23
No phaseRecruitingResearch participation
Nutriomics and Artificial Intelligence Nutrition Obesity Cohort
- Where
- Seoul
- Age
- 19 years and over
- People
- 650
- Run by
- Yonsei University
See details and how to joinNCT05494138Registry updated 2022-08-09
All Obesity trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.